UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.
UnitedHealth Dividend Announcement
• UnitedHealth announced a quarterly dividend of C$0.00 per ordinary share which will be made payable on . Ex dividend date: 2024-12-09
• UnitedHealth annual dividend for 2024 was C$0.29
• UnitedHealth annual dividend for 2023 was C$0.35
• UnitedHealth's trailing twelve-month (TTM) dividend yield is 2.25%
• UnitedHealth's payout ratio for the trailing twelve months (TTM) is 50.63%
UnitedHealth Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-09 | C$0.00 | quarterly | |
2024-09-16 | C$0.10 | quarterly | |
2024-06-17 | C$0.10 | quarterly | |
2024-03-08 | C$0.09 | quarterly | |
2023-12-01 | C$0.09 | quarterly | |
2023-09-08 | C$0.09 | quarterly | |
2023-06-15 | C$0.09 | quarterly | |
2023-03-10 | C$0.08 | quarterly | |
2022-12-02 | C$0.08 | quarterly | |
2022-09-09 | C$0.08 | quarterly |
UnitedHealth Dividend per year
UnitedHealth Dividend growth
UnitedHealth Dividend Yield
UnitedHealth current trailing twelve-month (TTM) dividend yield is 2.25%. Interested in purchasing UnitedHealth stock? Use our calculator to estimate your expected dividend yield:
UnitedHealth Financial Ratios
UnitedHealth Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy UnitedHealth stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.